Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for Triple-Negative breast cancer: combo aims to stop recurrence

NCT ID NCT06393374

Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 16 times

Summary

This phase 3 trial tests whether adding the experimental drug sacituzumab tirumotecan (MK-2870) to the immunotherapy pembrolizumab can better prevent breast cancer from coming back in people with triple-negative breast cancer who still had tumor after initial treatment. About 1,530 participants will be randomly assigned to receive either the new combination or standard care (pembrolizumab alone or with capecitabine). The study measures how long participants remain cancer-free and overall survival.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sacituzumab tirumotecan (MK-2870) combined with pembrolizumab
What this could lead to
If successful, this combination could offer a more effective treatment option to prevent breast cancer recurrence in high-risk patients.
What could go wrong
This is a large phase 3 trial, but the experimental drug combination may not prove superior to existing treatments and could have side effects like infusion reactions or fatigue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 1,530 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Dec 2037

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Has centrally confirmed TNBC, as defined by the most recent American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines * Has no evidence of locoregional or distant relapse, as assessed by the treating physician * Had neoadjuvant treatment based on the KEYNOTE-522 regimen (pembrolizumab with carboplatin/taxanes and pembrolizumab with anthracycline-based chemotherapy) followed by surgery according to National Comprehensive Cancer Network (NCCN) treatment guidelines for TNBC * Had adequate excision and surgical removal of all clinically evident disease in the breast and/or lymph nodes and have adequately recovered from surgery * Has non-pathologic complete response at surgery * Is able to continue on adjuvant pembrolizumab * Randomization must be conducted within 16 weeks from surgical resection * Completed adjuvant radiation therapy (if indicated) and recovered before randomization * Has provided tissue from the surgical resection for central laboratory determination of trophoblast cell surface antigen 2 (TROP2) status * If capable of producing sperm, the participant agrees to the following during the intervention period and for at least the time needed to eliminate each study intervention after the last dose of study intervention (120 days for sacituzumab tirumotecan and 95 days for capecitabine \[no restriction for pembrolizumab\]): agrees to refrain from donating sperm AND is either abstinent and agrees to remain abstinent or uses highly effective contraception * For females (assigned at birth), is not pregnant or breastfeeding and ≥1 of the following applies: is not a participant of childbearing potential (POCBP) OR is a POCBP and uses highly effective contraception after the last dose of study intervention (210 days for sacituzumab tirumotecan, 120 days for pembrolizumab, and 185 days for capecitabine). Abstains from breastfeeding during the study intervention period and for at least 120 days after study intervention * Participants who have AEs due to previous anticancer therapies must have recovered to ≤Grade 1 or baseline (except alopecia) * Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy (ART) * An Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 assessed within 7 days before first dose of study treatment * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B birus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load prior to randomization Exclusion Criteria: * Has a known germline breast cancer gene (BRCA) mutation (deleterious or suspected deleterious) and is eligible for adjuvant therapy with olaparib where olaparib is approved and available * Has Grade \>2 peripheral neuropathy * History of documented severe dry eye syndrome, severe Meibomian gland disease and/or blepharitis, or severe corneal disease that prevents/delays corneal healing * Has active inflammatory bowel disease requiring immunosuppressive medication or previous history of inflammatory bowel disease (eg, Crohn's disease, ulcerative colitis, or chronic diarrhea) * Has uncontrolled, significant cardiovascular disease or cerebrovascular disease including New York Heart Association Class III or IV congestive heart failure, unstable angina, myocardial infarction, uncontrolled symptomatic arrhythmia, prolongation of QTcF interval to \>480 ms, and/or other serious cardiovascular and cerebrovascular diseases within 6 months prior to study intervention * Received prior treatment with a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) or a topoisomerase I inhibitor-containing ADC * Received anticancer therapy in the adjuvant phase including but not limited to chemotherapy, small molecule anticancer drugs, poly (adenosine diphosphate ribose) polymerase (PARP) inhibitors, ADCs, and/or immunotherapy, with the exception of adjuvant radiation therapy * Is currently receiving a strong inducer/inhibitor of cytochrome P450 3A4 (CYP3A4) that cannot be discontinued for the duration of the study. The required washout period before starting sacituzumab tirumotecan is 2 weeks * Except for pembrolizumab as neoadjuvant therapy for early-stage TNBC: received prior therapy with an anti-programmed cell death 1 protein (anti-PD-1), anti-programmed cell death ligand 1 (anti-PD-L1), or anti-PD-L2 agent, or with an agent directed to another stimulatory or coinhibitory T-cell receptor (eg, cytotoxic T-lymphocyte-associated protein-4 \[CTLA-4\], OX-40 \[cluster of differentiation (CD) 134\], or CD137) * Except for chemotherapy as neoadjuvant therapy for early-stage TNBC: Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization * Received prior radiotherapy within 3 weeks of start of study intervention or required corticosteroids for radiation related toxicities that cannot be discontinued before the first dose of study intervention * Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. Administration of killed vaccines are allowed * Has received an investigational agent or has used an investigational device within 4 weeks prior to study intervention administration * Has known additional malignancy that is progressing or has required active treatment within the past 5 years * Has diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study medication * Has active autoimmune disease that has required systemic treatment in the past 2 years. Replacement therapy (eg, thyroxine, insulin, or physiologic corticosteroid) is allowed * Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease * Has active infection requiring systemic therapy * HIV-infected participants with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease * Has concurrent active hepatitis B and hepatitis C virus infection * Has history of allogeneic tissue/solid organ transplant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Triple-negative breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Triple-negative breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    298 sites in 31 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • ANIMI - Unidade de Tratamento Oncologico ( Site 0616)

    RECRUITING

    Lages, Santa Catarina, 88501-001, Brazil

  • AZ Maria Middelares-IKG ( Site 0903)

    RECRUITING

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • Aalborg Universitetshospital, Syd ( Site 3206)

    RECRUITING

    Aalborg, North Denmark, 9000, Denmark

  • Aarhus Universitets hospital ( Site 3202)

    RECRUITING

    Aarhus N, Central Jutland, 8200, Denmark

  • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2501)

    RECRUITING

    Adana, 01140, Turkey (Türkiye)

  • AdventHealth Altamonte Springs ( Site 0125)

    RECRUITING

    Altamonte Springs, Florida, 32701, United States

  • Akademiska Sjukhuset ( Site 3501)

    RECRUITING

    Uppsala, Uppsala County, 751 85, Sweden

  • Altru Cancer Center ( Site 0104)

    RECRUITING

    Grand Forks, North Dakota, 58201, United States

  • Archbold Memorial Hospital-Lewis Hall Singletary Oncology Center ( Site 0040)

    COMPLETED

    Thomasville, Georgia, 31792, United States

  • Aretaieio Hospital Oncology Unit ( Site 1505)

    RECRUITING

    Athens, Attica, 115 28, Greece

  • Asan Medical Center-Department of Oncology ( Site 3103)

    RECRUITING

    Seoul, 05505, South Korea

  • Azienda Ospedaliera Spedali Civili di Brescia ( Site 1812)

    RECRUITING

    Brescia, Lombardy, 25123, Italy

  • Azienda Ospedaliera Universitaria Careggi ( Site 1805)

    RECRUITING

    Florence, Tuscany, 50134, Italy

  • Azienda Ospedaliero Universitaria Maggiore della Carità-SCDU ONCOLOGIA ( Site 1804)

    RECRUITING

    Novara, 28100, Italy

  • BC Cancer Vancouver ( Site 0404)

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Baptist Cancer Center ( Site 0101)

    RECRUITING

    Memphis, Tennessee, 38120, United States

  • Bass Medical Group ( Site 0089)

    COMPLETED

    Walnut Creek, California, 94598, United States

  • Bialostockie Centrum Onkologii ( Site 2105)

    COMPLETED

    Bialystok, Podlaskie Voivodeship, 15-027, Poland

  • Bon Secours Cork Hospital ( Site 1600)

    RECRUITING

    Cork, T12 DV56, Ireland

  • Bon Secours Memorial Regional Medical Center-Oncology Research Department ( Site 0020)

    RECRUITING

    Midlothian, Virginia, 23114, United States

  • Brust-Zentrum ( Site 2401)

    RECRUITING

    Zurich, Canton of Zurich, 8008, Switzerland

  • CENEIT Oncologicos ( Site 0706)

    RECRUITING

    Mexico City, Mexico City, 03100, Mexico

  • CENTRE LEON BERARD ( Site 1300)

    RECRUITING

    Lyon Cedex08, Auvergne-Rhône-Alpes, 69373, France

  • CENTRO MEDICO ZAMBRANO HELLION ( Site 0711)

    RECRUITING

    San Pedro Garza García, Nuevo León, 66278, Mexico

  • CHRISTUS St. Frances Cabrini Hospital Center for Cancer Care ( Site 0109)

    RECRUITING

    Alexandria, Louisiana, 71301, United States

  • CHRISTUS St. Vincent Regional Cancer Center ( Site 0118)

    RECRUITING

    Santa Fe, New Mexico, 87505, United States

  • CHRU Brest - Hopital Cavale Blanche ( Site 1304)

    RECRUITING

    Brest, Finistere, 29200, France

  • CHU Besançon ( Site 1311)

    COMPLETED

    Besançon, Doubs, 25000, France

  • CHUAC-Hospital Teresa Herrera-MEDICAL ONCOLOGY ( Site 2307)

    RECRUITING

    A Coruña, La Coruna, 15006, Spain

  • CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0419)

    RECRUITING

    Montreal, Quebec, H1T 2M4, Canada

  • COI Centro Oncologico Internacional S.A.P.I. de C.V. ( Site 0712)

    RECRUITING

    Mexico City, Mexico City, 04700, Mexico

  • CRO-IRCCS ( Site 1808)

    RECRUITING

    Aviano, Friuli Venezia Giulia, 33081, Italy

  • Cancer Care Associates Of York ( Site 9517)

    RECRUITING

    York, Pennsylvania, 17403, United States

  • Cancer Center of Kansas ( Site 0004)

    COMPLETED

    Wichita, Kansas, 67214, United States

  • Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0046)

    RECRUITING

    Grand Junction, Colorado, 81501, United States

  • Cancer Institute Hospital of JFCR ( Site 3404)

    RECRUITING

    Koto, Tokyo, 135-8550, Japan

  • Cancer and Blood Specialty Clinic ( Site 0008)

    COMPLETED

    Los Alamitos, California, 90720, United States

  • CancerCare Manitoba ( Site 0411)

    RECRUITING

    Winnipeg, Manitoba, R2H 2A6, Canada

  • Cape Fear Valley Health System ( Site 0136)

    RECRUITING

    Fayetteville, North Carolina, 28304, United States

  • Capio St. Gorans Sjukhus ( Site 3503)

    RECRUITING

    Stockholm, Stockholm County, 112 81, Sweden

  • CaritasKlinikum Saarbruecken St. Theresia ( Site 1410)

    RECRUITING

    Saarbrücken, Saarland, 66113, Germany

  • Centre Antoine-Lacassagne ( Site 1308)

    RECRUITING

    Nice, Alpes-Maritimes, 06189, France

  • Centre François Baclesse ( Site 1318)

    RECRUITING

    Caen, Calvados, 14076, France

  • Centre Georges François Leclerc ( Site 1312)

    RECRUITING

    Dijon, Cote-d Or, 21079, France

  • Centre Henri Becquerel ( Site 1319)

    RECRUITING

    Rouen, Seine-Maritime, 76038, France

  • Centre Hospitalier de Pau ( Site 1302)

    RECRUITING

    Pau, Pyrenees-Atlantiques, 64046, France

  • Centre Hospitalier de l'Université de Montréal ( Site 0403)

    RECRUITING

    Montreal, Quebec, H2X 3E4, Canada

  • Centre Hospitalier de la Cote Basque ( Site 1315)

    RECRUITING

    Bayonne, Aquitaine, 64109, France

  • Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0417)

    RECRUITING

    Greenfield Park, Quebec, J4V 2H1, Canada

  • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 1307)

    RECRUITING

    Clermont-Ferrand, Auvergne, 63011, France

  • Centre de Cancerologie Les Dentellieres ( Site 1306)

    RECRUITING

    Valenciennes, Nord, 59300, France

  • Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0406)

    RECRUITING

    Trois-Rivières, Quebec, G8Z 3R9, Canada

  • Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0409)

    RECRUITING

    Rimouski, Quebec, G5L 5T1, Canada

  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0508)

    RECRUITING

    Buenos Aires, C1431FWO, Argentina

  • Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 2102)

    RECRUITING

    Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796, Poland

  • Cleveland Clinic - Mercy Hospital ( Site 0057)

    RECRUITING

    Canton, Ohio, 44708, United States

  • Cleveland Clinic Martin North Hospital ( Site 0114)

    RECRUITING

    Stuart, Florida, 34994, United States

  • Clinica Somer ( Site 3704)

    RECRUITING

    Rionegro, Antioquia, 054040, Colombia

  • Clinical Research Alliance ( Site 0086)

    RECRUITING

    Westbury, New York, 11590, United States

  • Clinique Générale-Beaulieu ( Site 2406)

    RECRUITING

    Geneva, Canton of Geneva, 1206, Switzerland

  • Clinique Tivoli Ducos ( Site 1322)

    RECRUITING

    Bordeaux, Gironde, 33000, France

  • Cliniques universitaires Saint-Luc-Medical Oncology ( Site 0901)

    RECRUITING

    Brussels, Bruxelles-Capitale, Region de, 1200, Belgium

  • Comprehensive Cancer Centers of Nevada - Peak ( Site 0047)

    RECRUITING

    Las Vegas, Nevada, 89128, United States

  • Comprehensive Hematology Oncology ( Site 0091)

    RECRUITING

    St. Petersburg, Florida, 33709, United States

  • Cross Cancer Institute ( Site 0407)

    RECRUITING

    Edmonton, Alberta, T6G 1Z2, Canada

  • Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi-oncology ( Site 2504)

    RECRUITING

    Ankara, 06200, Turkey (Türkiye)

  • Drammen Sykehus, Vestre Viken HF ( Site 2001)

    RECRUITING

    Drammen, Buskerud, 3004, Norway

  • Errikos Dunant Hospital Center-1st Medical Oncology Dept. ( Site 1508)

    RECRUITING

    Athens, Attica, 115 26, Greece

  • European Interbalkan Medical Center ( Site 1502)

    RECRUITING

    Thessaloniki, 570 01, Greece

  • European Interbalkan Medical Center ( Site 1507)

    RECRUITING

    Thessaloniki, 570 01, Greece

  • Evangelisches Krankenhaus Bethesda Mönchengladbach-Brustzentrum Niederrhein ( Site 1406)

    RECRUITING

    Mönchengladbach, North Rhine-Westphalia, 41061, Germany

  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 3700)

    RECRUITING

    Bogotá, Bogota D.C., 110131, Colombia

  • Fakultni Thomayerova nemocnice - Onkologicka klinika 1. LF UK a FTN ( Site 1008)

    RECRUITING

    Prague, Praha 4, 14059, Czechia

  • Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1006)

    RECRUITING

    Olomouc, Olomouc Region, 779 00, Czechia

  • Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 1000)

    RECRUITING

    Prague, Praha 5, 150 06, Czechia

  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1801)

    RECRUITING

    Milan, Lombardy, 20133, Italy

  • Fondazione IRCCS San Gerardo dei Tintori ( Site 1813)

    RECRUITING

    Monza, Lombardy, 20900, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1802)

    RECRUITING

    Rome, Lazio, 00168, Italy

  • Frankston Hospital-Oncology and Haematology ( Site 2704)

    RECRUITING

    Frankston, Victoria, 3199, Australia

  • Franziskus-Hospital Harderberg ( Site 1404)

    RECRUITING

    Georgsmarienhütte, Lower Saxony, 49124, Germany

  • Fukushima Medical University Hospital ( Site 3401)

    RECRUITING

    Fukushima, 960-1295, Japan

  • Fundacao Champalimaud ( Site 2200)

    RECRUITING

    Lisbon, 1400-038, Portugal

  • Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2303)

    RECRUITING

    Valencia, Valenciana, Comunitat, 46009, Spain

  • Gangnam Severance Hospital, Yonsei University Health System-Medical Oncology, Internal Medicine ( Site 3104)

    RECRUITING

    Seoul, 06273, South Korea

  • Genesis Healthcare System ( Site 0025)

    RECRUITING

    Zanesville, Ohio, 43701, United States

  • Gifu University Hospital ( Site 3426)

    RECRUITING

    Gifu, 501-1194, Japan

  • Grupo Médico ASSET SC ( Site 0705)

    RECRUITING

    Benito Juárez, Mexico City, 03100, Mexico

  • Gunma Prefectural Cancer Center ( Site 3428)

    RECRUITING

    Ōta, Gunma, 373-8550, Japan

  • Gävle sjukhus ( Site 3504)

    RECRUITING

    Gävle, Gävleborg County, 801 87, Sweden

  • HFR Fribourg - Hôpital Cantonal ( Site 2402)

    RECRUITING

    Fribourg, 1708, Switzerland

  • HOSPITAL CLINICO DE VALENCIA-Oncology ( Site 2302)

    RECRUITING

    Valencia, 46010, Spain

  • HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Medical Oncology ( Site 2308)

    RECRUITING

    Majadahonda, Madrid, Comunidad de, 28222, Spain

  • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 2304)

    RECRUITING

    Seville, Andalusia, 41013, Spain

  • Hadassah Medical Center ( Site 1700)

    RECRUITING

    Jerusalem, 9112001, Israel

  • Harrington Cancer Center ( Site 0061)

    RECRUITING

    Amarillo, Texas, 79106, United States

  • Health Pharma Professional Research S.A. de C.V: ( Site 0709)

    RECRUITING

    Mexico City, Mexico City, 03100, Mexico

  • Helen F. Graham Cancer Center & Research Institute ( Site 0018)

    RECRUITING

    Newark, Delaware, 19713, United States

  • Helios Klinikum Berlin-Buch-Klinik für Gynäkologie und Geburtshilfe ( Site 1413)

    RECRUITING

    Berlin, 13125, Germany

  • Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 1100)

    RECRUITING

    Helsinki, Uusimaa, 00029, Finland

  • Hematology Oncology Associates of Fredericksburg ( Site 9550)

    RECRUITING

    Fredericksburg, Virginia, 22408, United States

  • Hendrick Medical Center ( Site 0117)

    RECRUITING

    Abilene, Texas, 79601, United States

  • Henry Ford Health ( Site 0010)

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Herlev og Gentofte Hospital. ( Site 3203)

    RECRUITING

    Herlev, Capital Region, 2730, Denmark

  • Hightower Clinical, LLC ( Site 0085)

    COMPLETED

    Oklahoma City, Oklahoma, 73102, United States

  • Hiroshima City Hiroshima Citizens Hospital ( Site 3418)

    RECRUITING

    Hiroshima, 730-8518, Japan

  • Hokkaido University Hospital ( Site 3400)

    RECRUITING

    Sapporo, Hokkaido, 060-8648, Japan

  • Holy Cross Hospital ( Site 0069)

    RECRUITING

    Silver Spring, Maryland, 20910, United States

  • Hong Kong United Oncology Centre ( Site 3601)

    RECRUITING

    Kowloon, Hong Kong

  • Hospital Aleman-Oncology ( Site 0501)

    RECRUITING

    Capital Federal, Buenos Aires, C1118AAT, Argentina

  • Hospital Beata María Ana-oncology ( Site 2309)

    RECRUITING

    Madrid, 28007, Spain

  • Hospital Británico de Buenos Aires-Oncology ( Site 0502)

    RECRUITING

    Ciudad Autónoma de Buenos Aires, Buenos Aires, C1280AEB, Argentina

  • Hospital Clinico San Carlos-Oncology Department ( Site 2306)

    RECRUITING

    Madrid, 28040, Spain

  • Hospital Santa Rita de Cassia ( Site 0617)

    RECRUITING

    Vitória, Espírito Santo, 29043-260, Brazil

  • Hospital Universitari Vall d'Hebron-Oncology ( Site 2300)

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 2301)

    RECRUITING

    Madrid, Madrid, Comunidad de, 28034, Spain

  • Hospital do Câncer Mãe de Deus ( Site 0604)

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90110-270, Brazil

  • Humanitas Istituto Clinico Catanese ( Site 1811)

    RECRUITING

    Misterbianco, Catania, 95045, Italy

  • Hôpital Franco-Britannique - Fondation Cognacq-Jay ( Site 1321)

    RECRUITING

    Levallois-Perret, Hauts-de-Seine, 92300, France

  • Hôpital Privé Drôme-Ardèche ( Site 1301)

    RECRUITING

    Guilherand-Granges, Ardeche, 07500, France

  • Hôpital Tenon ( Site 1303)

    RECRUITING

    Paris, 75020, France

  • IBCC - Núcleo de Pesquisa e Ensino ( Site 0601)

    RECRUITING

    São Paulo, 04014-002, Brazil

  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 1807)

    RECRUITING

    Meldola (FC), Forli-Cesena, 47014, Italy

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1810)

    RECRUITING

    Bologna, 40138, Italy

  • Icahn School of Medicine at Mount Sinai ( Site 0123)

    RECRUITING

    New York, New York, 10029, United States

  • Illinois Cancer Specialists (ICS) ( Site 8010)

    RECRUITING

    Arlington Heights, Illinois, 60005, United States

  • Infirmary Cancer Care ( Site 0001)

    RECRUITING

    Mobile, Alabama, 36607, United States

  • Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2305)

    RECRUITING

    L'Hospitalet de Llobregat, Barcelona, 08908, Spain

  • Institut Paoli-Calmettes ( Site 1309)

    RECRUITING

    Marseille, Bouches-du-Rhone, 13009, France

  • Institut de Cancérologie de l'Ouest ( Site 1305)

    RECRUITING

    Saint-Herblain, Loire-Atlantique, 44805, France

  • Institut de Cancérologie de l'Ouest ( Site 1316)

    RECRUITING

    Angers, Maine-et-Loire, 49055, France

  • Instituto Alexander Fleming-Alexander Fleming ( Site 0509)

    RECRUITING

    Buenos Aires, Buenos Aires F.D., C1426ANZ, Argentina

  • Instituto Nacional De Cancerologia ( Site 3701)

    RECRUITING

    Bogotá, Bogota D.C., 111511, Colombia

  • Instituto Portugues de Oncologia do Porto ( Site 2202)

    RECRUITING

    Porto, 4200-072, Portugal

  • Instituto de Oncologia Saint Gallen ( Site 0614)

    RECRUITING

    Santa Cruz do Sul, Rio Grande do Sul, 96830-180, Brazil

  • Instituto de Oncología Angel H. Roffo ( Site 0503)

    RECRUITING

    Buenos Aires, Buenos Aires F.D., C1417, Argentina

  • Instituto do Câncer Brasil - Unidade Taubaté ( Site 0608)

    RECRUITING

    Taubaté, São Paulo, 12030-200, Brazil

  • Intermountain Medical Center ( Site 0113)

    RECRUITING

    Murray, Utah, 84107, United States

  • Ironwood Cancer & Research Centers-Research ( Site 0054)

    RECRUITING

    Chandler, Arizona, 85224, United States

  • Istituto Europeo di Oncologia IRCCS-Divisione di Senologia Medica ( Site 1809)

    RECRUITING

    Milan, Lombardy, 20141, Italy

  • Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Clinica Sperimentale di Senologia ( Site 1800)

    RECRUITING

    Naples, Campania, 80131, Italy

  • Jewish General Hospital ( Site 0416)

    RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

  • John Peter Smith Hospital ( Site 0106)

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • Juntendo University Hospital ( Site 3408)

    RECRUITING

    Bunkyo, Tokyo, 113-8431, Japan

  • Kaiser Permanente - Oakland ( Site 0079)

    RECRUITING

    Oakland, California, 94611, United States

  • Kaiser Permanente - Roseville ( Site 0081)

    RECRUITING

    Roseville, California, 95661, United States

  • Kaiser Permanente - San Francisco ( Site 0080)

    RECRUITING

    San Francisco, California, 94115, United States

  • Kaiser Permanente - Santa Clara ( Site 0082)

    RECRUITING

    Santa Clara, California, 95051, United States

  • Kaiser Permanente - Walnut Creek ( Site 0078)

    RECRUITING

    Walnut Creek, California, 94596, United States

  • Kaiser Permanente Vallejo Medical Center ( Site 0060)

    RECRUITING

    Vallejo, California, 94589, United States

  • Kanagawa Cancer Center ( Site 3412)

    RECRUITING

    Yokohama, Kanagawa, 241-8515, Japan

  • Kantonsspital Graubünden-Medizin ( Site 2404)

    COMPLETED

    Chur, Kanton Graubünden, 7000, Switzerland

  • Karolinska Universitetssjukhuset Solna ( Site 3500)

    RECRUITING

    Stockholm, Stockholm County, 171 76, Sweden

  • Kepler Universitätsklinikum-Department for Oncology and Hematology ( Site 1206)

    RECRUITING

    Linz, Upper Austria, 4020, Austria

  • Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 0422)

    RECRUITING

    Kingston, Ontario, K7L 2V7, Canada

  • Kitasato University Hospital ( Site 3411)

    RECRUITING

    Sagamihara, Kanagawa, 252-0375, Japan

  • Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung-Klinik für Senologie/ Brustzentrum ( Site 1401)

    RECRUITING

    Essen, North Rhine-Westphalia, 45136, Germany

  • Klinikum Ernst von Bergmann-Frauenklinik ( Site 1408)

    RECRUITING

    Potsdam, Brandenburg, 14467, Germany

  • Klinikum Ludwigsburg-Klinik für Geburtshilfe und Frauenheilkunde ( Site 1405)

    RECRUITING

    Ludwigsburg, Baden-Wurttemberg, 71640, Germany

  • Klinikum Mutterhaus der Borromäerinnen ( Site 1420)

    RECRUITING

    Trier, Rhineland-Palatinate, 54290, Germany

  • Klinikum Wels-Grieskirchen ( Site 1205)

    RECRUITING

    Wels, Upper Austria, 4600, Austria

  • Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Frauenklinik Brustzentrum ( Site 1402)

    RECRUITING

    Munich, Bavaria, 80336, Germany

  • Kumamoto University Hospital ( Site 3420)

    RECRUITING

    Kumamoto, 860-8556, Japan

  • Kuopion Yliopistollinen Sairaala-Syöpäkeskus ( Site 1101)

    RECRUITING

    Kuopio, Northern Savonia, 70210, Finland

  • Kyoto University Hospital ( Site 3415)

    RECRUITING

    Kyoto, 606-8507, Japan

  • Laguna Clinical Research Associates LLC ( Site 0068)

    RECRUITING

    Laredo, Texas, 78041, United States

  • Lake Regional Hospital ( Site 0009)

    RECRUITING

    Osage Beach, Missouri, 65065, United States

  • Levine Cancer Institute ( Site 0083)

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Louisiana State University Health Sciences Shreveport ( Site 0029)

    RECRUITING

    Shreveport, Louisiana, 71103, United States

  • Macquarie University-MQ Health Clinical Trials Unit ( Site 2703)

    RECRUITING

    Macquarie University, New South Wales, 2109, Australia

  • Marien Hospital Witten ( Site 1424)

    RECRUITING

    Witten, North Rhine-Westphalia, 58452, Germany

  • Mary Washington Hospital ( Site 0129)

    RECRUITING

    Fredericksburg, Virginia, 22405, United States

  • Masarykuv onkologicky ustav ( Site 1005)

    RECRUITING

    Brno, Brno-mesto, 656 53, Czechia

  • Mays Cancer Center ( Site 0122)

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Mazowiecki Szpital Onkologiczny-BREAST CANCER ( Site 2101)

    RECRUITING

    Wieliszew, Masovian Voivodeship, 05-135, Poland

  • Medipol Mega Universite Hastanesi-oncology ( Site 2503)

    RECRUITING

    Istanbul, 34214, Turkey (Türkiye)

  • Medizinische Hochschule Hannover ( Site 1419)

    RECRUITING

    Hanover, Lower Saxony, 30625, Germany

  • Medizinische Universitaet Innsbruck ( Site 1200)

    RECRUITING

    Innsbruck, Tyrol, 6020, Austria

  • Medizinische Universität Wien-Universitätsklinik für Innere Medizin I, Klinische Abteilung für Onko ( Site 1201)

    RECRUITING

    Vienna, 1090, Austria

  • Memorial Ankara Hastanesi-Medical Oncology ( Site 2502)

    RECRUITING

    Ankara, 06520, Turkey (Türkiye)

  • Memorial Sloan Kettering Cancer Center ( Site 0067)

    RECRUITING

    New York, New York, 10065, United States

  • MemorialCare Orange Coast Medical Center ( Site 9501)

    RECRUITING

    Fountain Valley, California, 92708, United States

  • Metro-Minnesota Community Clinical Oncology ( Site 0031)

    RECRUITING

    Saint Louis Park, Minnesota, 55426, United States

  • Mie University Hospital ( Site 3423)

    RECRUITING

    Tsu, Mie-ken, 514-8507, Japan

  • Nagoya City University Hospital ( Site 3414)

    RECRUITING

    Nagoya, Aichi-ken, 467-8602, Japan

  • Narodowy Instytut Onkologii - Oddzial w Gliwicach-Centrum Diagnostyki i Leczenia Chorob Piersi ( Site 2110)

    RECRUITING

    Gliwice, Silesian Voivodeship, 44-102, Poland

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 2120)

    RECRUITING

    Krakow, Lesser Poland Voivodeship, 31-115, Poland

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Piersi i Chirurgii ( Site 2100)

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • Nashville General Hospital ( Site 0072)

    COMPLETED

    Nashville, Tennessee, 37208, United States

  • National Cancer Center Hospital East ( Site 3403)

    RECRUITING

    Kashiwa, Chiba, 277-8577, Japan

  • National Cancer Centre Singapore-Medical Oncology ( Site 3002)

    RECRUITING

    Singapore, Central Singapore, 168583, Singapore

  • National Center for Global Health and Medicine ( Site 3409)

    RECRUITING

    Shinjuku, Tokyo, 162-8655, Japan

  • Nemocnice Ceske Budejovice-Onkologicke oddeleni ( Site 1007)

    RECRUITING

    České Budějovice, South Bohemian Region, 37001, Czechia

  • New Mexico Oncology Hematology Consultants Ltd. ( Site 0090)

    RECRUITING

    Albuquerque, New Mexico, 87109, United States

  • North York General Hospital ( Site 0415)

    RECRUITING

    Toronto, Ontario, M2K 1E1, Canada

  • Northwest Cancer Center - Dyer Clinic ( Site 0097)

    RECRUITING

    Dyer, Indiana, 46311, United States

  • Northwest Medical Specialties, PLLC ( Site 0093)

    RECRUITING

    Tacoma, Washington, 98405, United States

  • Ochsner LSU Health - Monroe Medical Center, Family Medicine Clinic ( Site 0063)

    COMPLETED

    Monroe, Louisiana, 71202, United States

  • Odense Universitetshospital ( Site 3201)

    RECRUITING

    Odense C, Region Syddanmark, 5000, Denmark

  • Okayama University Hospital ( Site 3425)

    RECRUITING

    Okayama, 700-8558, Japan

  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0041)

    RECRUITING

    Tulsa, Oklahoma, 74146, United States

  • Oncare - Unidad Valle ( Site 0713)

    RECRUITING

    San Pedro Garza García, Nuevo León, 66220, Mexico

  • Oncoclínica Oncologistas Associados-Clinical Research ( Site 0607)

    RECRUITING

    Teresina, Piauí, 64049-200, Brazil

  • Oncology Consultants P.A. ( Site 0107)

    RECRUITING

    Houston, Texas, 77030, United States

  • One Oncology - Tennessee Oncology ( Site 0098)

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Optum Care Cancer Center ( Site 9535)

    RECRUITING

    Las Vegas, Nevada, 89102, United States

  • Orchard Healthcare Research Inc. ( Site 0014)

    RECRUITING

    Skokie, Illinois, 60077, United States

  • Orlando Health Cancer Institute ( Site 0030)

    RECRUITING

    Orlando, Florida, 32806, United States

  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 3417)

    RECRUITING

    Osaka, 541-8567, Japan

  • Oslo universitetssykehus, Radiumhospitalet ( Site 2002)

    RECRUITING

    Oslo, 0379, Norway

  • Ospedale San Raffaele-Oncologia Medica ( Site 1814)

    RECRUITING

    Milan, 20132, Italy

  • PRONUTRIR-CLINICAL RESEARCH ( Site 0609)

    RECRUITING

    Fortaleza, Ceará, 60810-180, Brazil

  • Pantai Hospital Kuala Lumpur ( Site 2801)

    RECRUITING

    Kuala Lumpur, 59100, Malaysia

  • Parkland Health & Hospital System ( Site 0096)

    RECRUITING

    Dallas, Texas, 75390, United States

  • Parkview Research Center at Parkview Regional Medical Center ( Site 0011)

    RECRUITING

    Fort Wayne, Indiana, 46845, United States

  • Praxis fuer interdisziplinaere Onkologie und Haematologie ( Site 1423)

    RECRUITING

    Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany

  • Prince Court Medical Centre ( Site 2802)

    RECRUITING

    Kuala Lumpur, 50450, Malaysia

  • Prince of Wales Hospital ( Site 3602)

    RECRUITING

    Shatin, 000000, Hong Kong

  • Princess Margaret Cancer Centre ( Site 0400)

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Profound Research LLC ( Site 0074)

    COMPLETED

    Royal Oak, Michigan, 48073, United States

  • Profound Research LLC ( Site 0105)

    RECRUITING

    Oceanside, California, 92056, United States

  • Providence Medical Foundation ( Site 9543)

    RECRUITING

    Santa Rosa, California, 95403, United States

  • Providence Oncology and Hematology Care Clinic - Westside ( Site 0126)

    RECRUITING

    Portland, Oregon, 97225, United States

  • Providence Portland Medical Center ( Site 0116)

    RECRUITING

    Portland, Oregon, 97213, United States

  • QEII Health Sciences Centre - Victoria General Site ( Site 0418)

    RECRUITING

    Halifax, Nova Scotia, B3H 2Y9, Canada

  • Queen Mary Hospital ( Site 3600)

    RECRUITING

    Hong Kong, Hong Kong

  • Rabin Medical Center ( Site 1702)

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Site 2701)

    RECRUITING

    Brisbane, Queensland, 4029, Australia

  • SCRI Oncology Partners ( Site 7000)

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • SSM Health Cancer Care - Fenton ( Site 0088)

    COMPLETED

    Fenton, Missouri, 63026, United States

  • SSM Health Dean Medical Group ( Site 0087)

    RECRUITING

    Madison, Wisconsin, 53715, United States

  • Sahlgrenska Universitetssjukhuset. ( Site 3505)

    RECRUITING

    Gothenburg, Västra Götaland County, 413 45, Sweden

  • Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0044)

    RECRUITING

    Edgewood, Kentucky, 41017, United States

  • Saitama Medical University International Medical Center ( Site 3402)

    RECRUITING

    Hidaka, Saitama, 350-1298, Japan

  • Samsun Medical Park Hastanesi-medical oncology ( Site 2500)

    RECRUITING

    Samsun, 55200, Turkey (Türkiye)

  • Samsung Medical Center-Division of Hematology/Oncology ( Site 3101)

    RECRUITING

    Seoul, 06351, South Korea

  • Sanatorio Finochietto ( Site 0513)

    RECRUITING

    Buenos Aires, C1187AAN, Argentina

  • Sanatorio Parque ( Site 0512)

    RECRUITING

    Rosario, Santa Fe Province, S2000DSV, Argentina

  • Sanford Cancer Center ( Site 0059)

    RECRUITING

    Sioux Falls, South Dakota, 57104, United States

  • Sanford Cancer Center Bismarck ( Site 0058)

    RECRUITING

    Bismarck, North Dakota, 58501, United States

  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0056)

    RECRUITING

    Fargo, North Dakota, 58102, United States

  • Scripps Cancer Center ( Site 0052)

    RECRUITING

    La Jolla, California, 92037, United States

  • Seoul National University Hospital-Internal Medicine ( Site 3102)

    RECRUITING

    Seoul, 03080, South Korea

  • Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3100)

    RECRUITING

    Seoul, 03722, South Korea

  • Shaare Zedek Medical Center ( Site 1706)

    RECRUITING

    Jerusalem, 9103102, Israel

  • Sheba Medical Center-ONCOLOGY ( Site 1701)

    RECRUITING

    Ramat Gan, 5265601, Israel

  • Showa Medical University Hospital ( Site 3406)

    RECRUITING

    Shinagawa, Tokyo, 142-8666, Japan

  • Sidney Kimmel Cancer Center at Jefferson ( Site 0049)

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • Siteman Cancer Center ( Site 0099)

    RECRUITING

    St Louis, Missouri, 63108, United States

  • Social medical corporation Hakuaikai Sagara Hospital ( Site 3421)

    RECRUITING

    Kagoshima, 892-0833, Japan

  • Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 3705)

    RECRUITING

    Valledupar, Cesar Department, 200001, Colombia

  • Soroka Medical Center-Oncology ( Site 1704)

    RECRUITING

    Beersheba, 8410101, Israel

  • Sourasky Medical Center ( Site 1705)

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Southern Illinois Hospital Services ( Site 9547)

    RECRUITING

    Carterville, Illinois, 62918, United States

  • Southlake Health ( Site 0413)

    COMPLETED

    Newmarket, Ontario, L3Y 2P9, Canada

  • Spital Thun ( Site 2400)

    RECRUITING

    Thun, Canton of Bern, 3600, Switzerland

  • St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 2602)

    RECRUITING

    London, London, City of, EC1A 7BE, United Kingdom

  • St James's University Hospital-Leeds Cancer Centre ( Site 2608)

    RECRUITING

    Leeds, LS9 7TF, United Kingdom

  • St. Marianna University Hospital ( Site 3405)

    RECRUITING

    Kawasaki, Kanagawa, 216-8511, Japan

  • St. Vincent's University Hospital-Medical Oncology Research Department ( Site 1601)

    RECRUITING

    Dublin, D04 T6F4, Ireland

  • St.Luke's International Hospital ( Site 3427)

    RECRUITING

    Chūō, Tokyo, 104-8560, Japan

  • Stavanger Universitetssykehus ( Site 2004)

    RECRUITING

    Stavanger, Rogaland, 4011, Norway

  • Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 2118)

    RECRUITING

    Kielce, Świętokrzyskie Voivodeship, 25-734, Poland

  • Sygehus Soenderjylland ( Site 3204)

    RECRUITING

    Sønderborg, Region Syddanmark, 6400, Denmark

  • Szpitale Pomorskie Sp. z o. o.-Oddział Onkologii Klinicznej ( Site 2113)

    RECRUITING

    Gdynia, Pomeranian Voivodeship, 81-519, Poland

  • Södra Älvsborg Sjukhus ( Site 3502)

    RECRUITING

    Borås, Västra Götaland County, 501 82, Sweden

  • Tampereen yliopistollinen sairaala ( Site 1102)

    RECRUITING

    Tampere, Pirkanmaa, 33520, Finland

  • Taylor Cancer Research Center ( Site 9500)

    RECRUITING

    Maumee, Ohio, 43537, United States

  • Tennessee Oncology ( Site 0111)

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Texas Oncology - DFW ( Site 8000)

    RECRUITING

    Dallas, Texas, 75246, United States

  • Texas Oncology - Gulf Coast ( Site 8009)

    RECRUITING

    Webster, Texas, 77598, United States

  • Texas Oncology - Northeast Texas ( Site 8005)

    RECRUITING

    Flower Mound, Texas, 75028, United States

  • The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0135)

    RECRUITING

    New York, New York, 10011, United States

  • The Moncton Hospital ( Site 0401)

    RECRUITING

    Moncton, New Brunswick, E1C 6Z8, Canada

  • The Ottawa Hospital - General Campus ( Site 0414)

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • The Royal Cornwall Hospital ( Site 2603)

    RECRUITING

    Truro, England, TR1 3LJ, United Kingdom

  • The University of Osaka Hospital ( Site 3416)

    RECRUITING

    Suita, Osaka, 565-0871, Japan

  • The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0055)

    RECRUITING

    Tyler, Texas, 75701, United States

  • Tohoku University Hospital ( Site 3422)

    RECRUITING

    Sendai, Miyagi, 980-8574, Japan

  • Tokai University Hospital ( Site 3413)

    RECRUITING

    Isehara, Kanagawa, 259-1193, Japan

  • Tokyo Medical University Hospital ( Site 3407)

    RECRUITING

    Shinjuku, Tokyo, 160-0023, Japan

  • Tri-County Hematology & Oncology Associates, Inc. ( Site 0076)

    RECRUITING

    Massillon, Ohio, 44646, United States

  • Turku University Hospital-Department of Oncology ( Site 1103)

    RECRUITING

    Turku, Southwest Finland, 20520, Finland

  • UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1509)

    RECRUITING

    Pátrai, Achaia, 26504, Greece

  • Unidade Local de Saude Amadora/Sintra - Hospital Prof Dr Fernando Fonseca ( Site 2203)

    RECRUITING

    Amadora, Lisbon District, 2720-276, Portugal

  • Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 2201)

    RECRUITING

    Lisbon, 1649-035, Portugal

  • Uniklinikum Salzburg-Universitätsklinik für Innere Medizin III der PMU mit Hämatologie, internistis ( Site 1202)

    RECRUITING

    Salzburg, 5020, Austria

  • Universitaetsklinikum Duesseldorf-Klinik für Frauenheilkunde & Geburtshilfe ( Site 1409)

    RECRUITING

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

  • Universitaetsklinikum Erlangen-Klinik für Gynäkologie und Geburtshilfe ( Site 1400)

    RECRUITING

    Erlangen, Bavaria, 91054, Germany

  • Universitaetsklinikum Tuebingen-Frauenklinik ( Site 1415)

    RECRUITING

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • University College Hospital - Galway ( Site 1602)

    RECRUITING

    Galway, Galway, Ireland

  • University College London Hospital ( Site 2604)

    RECRUITING

    London, London, City of, NW1 2PG, United Kingdom

  • University General Hospital of Larissa ( Site 1503)

    RECRUITING

    Larissa, Thessaly, 411 10, Greece

  • University Hospitals Bristol NHS Foundation Trust ( Site 2601)

    RECRUITING

    Bristol, Bristol, City of, BS2 8ED, United Kingdom

  • University of Connecticut Health Center ( Site 0128)

    RECRUITING

    Farmington, Connecticut, 06030, United States

  • University of Michigan ( Site 0103)

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • University of Mississippi Medical Center ( Site 0043)

    RECRUITING

    Jackson, Mississippi, 39216, United States

  • University of Naples Federico II-Dipartimento di Medicina Clinica e Chirurgia ( Site 1803)

    RECRUITING

    Naples, Campania, 80100, Italy

  • University of Texas Southwestern Medical Center ( Site 0032)

    RECRUITING

    Dallas, Texas, 75390, United States

  • Universitätsklinikum Schleswig-Holstein ( Site 1411)

    RECRUITING

    Lübeck, Schleswig-Holstein, 23538, Germany

  • Universitätsmedizin Johannes Gutenberg Universität Mainz-Klinik und Poliklinik für Geburtshilfe und ( Site 1418)

    RECRUITING

    Mainz, Rhineland-Palatinate, 55131, Germany

  • Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 0902)

    RECRUITING

    Namur, 5530, Belgium

  • Vanderbilt Health One Hundred Oaks ( Site 0042)

    RECRUITING

    Nashville, Tennessee, 37212, United States

  • Vejle Sygehus. ( Site 3205)

    RECRUITING

    Vejle, Region Syddanmark, 7100, Denmark

  • Virginia Cancer Institute ( Site 0034)

    RECRUITING

    Richmond, Virginia, 23229, United States

  • Virginia Oncology Associates (VOA) ( Site 8008)

    RECRUITING

    Norfolk, Virginia, 23502, United States

  • Vseobecna fakultni nemocnice v Praze-Onkologická klinika VFN ( Site 1002)

    RECRUITING

    Prague, Praha 2, 128 08, Czechia

  • West Cancer Center and Research Institute ( Site 0084)

    RECRUITING

    Germantown, Tennessee, 38138, United States

  • Western General Hospital ( Site 2607)

    RECRUITING

    Edinburgh, Midlothian, EH4 2XU, United Kingdom

  • Westmead Hospital ( Site 2700)

    RECRUITING

    Westmead, New South Wales, 2145, Australia

  • Yale Cancer Center ( Site 0053)

    RECRUITING

    New Haven, Connecticut, 06510, United States

  • Zachodniopomorskie Centrum Onkologii ( Site 2108)

    RECRUITING

    Szczecin, West Pomeranian Voivodeship, 71-730, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.